FDA Approves Non-Addictive Painkiller to Combat Opioid Addiction Crisis
FDA Approves Journavx: A Groundbreaking Non-Opioid Pain Relief Pill In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Journavx, a novel pain medication developed by Vertex Pharmaceuticals, designed to address the growing crisis of opioid addiction and overdose. This approval marks the first new pharmaceutical approach to pain management in over … Read more